Related Experiment Videos
[The niacin test in schizophrenia]
1Katedry i Kliniki Psychiatrii AM w Bydgoszczy.
Psychiatria Polska
|March 1, 1990
Summary
The niacin test, used to assess schizophrenia, showed limited diagnostic value. While most schizophrenic and all depressed patients experienced skin flushing, the test did not reveal significant differences, suggesting a potential metabolic defect in some schizophrenics.
Area of Science:
- Neuroscience
- Psychiatry
- Biochemistry
Background:
- The niacin test, involving oral administration of nicotinic acid, is sometimes used to evaluate physiological responses in psychiatric conditions.
- Schizophrenia and endogenous depression present complex symptomatology, necessitating reliable diagnostic and research tools.
Purpose of the Study:
- To evaluate the diagnostic utility and physiological response patterns of the niacin test in drug-free patients with active schizophrenia and endogenous depression.
- To investigate potential correlations between niacin-induced erythema and clinical features or temperature changes in these patient groups.
Main Methods:
- Oral administration of 200 mg of nicotinic acid to 33 schizophrenic and 18 endogenous depressed patients with significant symptoms.
- Assessment of erythema reaction and measurement of maximal left ear lobe temperature increase and time to peak response post-administration.
Main Results:
- Erythema reaction observed in 76% of schizophrenic patients and 100% of depressed patients.
- No significant differences in basal clinical features, temperature increase, or time to response were found between schizophrenic patients with or without erythema, or compared to depressed patients.
Conclusions:
- The niacin test demonstrates limited usefulness as a diagnostic tool for schizophrenia.
- Findings suggest a possible underlying metabolic defect, potentially related to reduced prostaglandin E1 (PGE1) activity, in a subset of schizophrenic patients.